Table 2.

Spearman correlation between different HDL-associated miRNAs and clinical characteristics at baseline before surgery

Characteristics	miR-24	miR-126	miR-222	miR-223
Age (years)	−0.012	−0.127	−0.232	0.005
Height (m)	−0.019	−0.258	−0.074	−0.042
BMI (kg/m2)	−0.164	−0.122	−0.038	−0.241
Waist circumference (cm)	−0.259	−0.108	0.030	−0.256
SBP (mm Hg)	−0.115	−0.118	−0.124	−0.099
DBP (mm Hg)	−0.222	-0.272a	-0.467a	-0.320a
Total cholesterol (mmol/l)	0.426b	0.549c	0.220	0.461c
Triglycerides (mmol/l)	0.156	0.071	0.157	0.060
HDL-C (mmol/l)	0.373b	0.459c	−0.252	0.495c
LDL-C (mmol/l)	0.318a	0.462c	0.288	0.350a
ApoA-I (g/l)	0.127	0.142	−0.218	0.235
ApoB (g/l)	0.372b	0.498c	0.077	0.397b
Cholesterol efflux capacity (%)	0.352a	0.449b	0.202	0.307a
PON1 activity (nmol/ml/min)	0.340a	0.427b	−0.069	0.242
HbA1c (mmol/l)	−0.021	−0.079	−0.238	−0.085
Fasting glucose (mmol/l)	0.025	0.056	−0.213	0.113
Fasting insulin (mU/l)	0.087	0.142	−0.201	0.070
HOMA-IR, ratio	0.061	0.121	−0.336	0.094
HOMA-B, %	0.091	0.072	−0.043	−0.023
ICAM-1 (ng/ml)	−0.111	-0.382a	−0.127	-0.281a
Adiponectin (mg/l)	0.200	0.095	0.034	0.155
Leptin (ng/ml)	0.110	0.055	−0.021	0.002
Resistin (ng/ml)	−0.041	−0.090	0.388	-0.275a

SBP, systolic blood pressure; DBP, diastolic blood pressure.

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.